| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | importazole | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0092 | 0.8 |